enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Bupropion/zonisamide - Wikipedia

   en.wikipedia.org/wiki/Bupropion/zonisamide

   Bupropion/zonisamide (former tentative brand name Empatic, Excalia) is an experimental combination of bupropion which was under development for the treatment of obesity. [1] [2] [3] Bupropion is a norepinephrine–dopamine reuptake inhibitor and nicotinic acetylcholine receptor antagonist, while zonisamide is an anticonvulsant acting as a sodium channel blocker, T-type calcium channel blocker ...

3. Weight Loss Injections: What You Need to Know, From ... - AOL

   www.aol.com/lifestyle/weight-loss-injections...

   An FDA-approved weight loss medication, naltrexone-bupropion is generally considered effective and safe to use. You may experience side effects like dizziness, mood changes, trouble sleeping, and ...

4. What are the best prescription weight loss pills? - AOL

   www.aol.com/best-prescription-weight-loss-pills...

   One analysis of these same clinical trials reported the overall average weight loss on naltrexone/bupropion to be a little over 4% ... Review the prescribing information for any weight loss pill ...

5. Naltrexone/bupropion - Wikipedia

   en.wikipedia.org/wiki/Naltrexone/bupropion

   Naltrexone/bupropion, sold under the brand name Contrave among others, is a fixed-dose combination medication for the management of chronic obesity in adults in combination with a reduced-calorie diet and increased physical activity.

6. Bupropion - Wikipedia

   en.wikipedia.org/wiki/Bupropion

   Bupropion, when used for treating long-term weight gain over six to twelve months, results in an average weight loss of 2.7 kilograms (6.0 lb) over placebo. [74] This is not much different from the weight loss produced by several other weight-loss medications such as sibutramine or orlistat . [ 74 ]

7. Study pinpoints 3 common antidepressants tied to the most ...

   www.aol.com/study-pinpoints-3-common...

   Bupropion had an associated 15% reduced risk of gaining 5% of baseline weight or more. At the 1-year and 2-year marks compared to sertraline, bupropion’s estimations for weight gain were still ...